![]() |
Conversations in Lung Cancer ResearchAuthor: Thoracic Oncology Group Of Australasia (TOGA)
Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and the latest updates on clinical trials. Stay informed and empowered in the fight against lung cancer. Language: en Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it Trailer: |
Listen Now...
The Evolving Role of Radiation Oncology in Lung Cancer Management
Episode 78
Thursday, 29 October, 2026
In this episode of TOGA's Conversations in Lung Cancer Research, host Prof. Shalini Vinod (Radiation Oncologist, Liverpool Hospital, Sydney) and guests Dr. Dasantha Jayamanne (Radiation Oncologist, Royal North Shore Hospital, Sydney, and GenesisCare) and Dr. Jane Ludbrook (Radiation Oncologist, Calvary Mater Hospital, Newcastle) discuss the rapid technological and clinical advancements in thoracic radiation oncology. They cover the evolving roles of Stereotactic Ablative Body Radiotherapy (SABR/SBRT) across different stages of non-small cell lung cancer (NSCLC), recent Australian clinical trial updates, strategies for reducing toxicity, and future directions in radiation therapy. Trials Mentioned: ViTAL: https://thoraciconcology.org.au/news/clinical-trials/innovative-imaging-trial-aims-to-reduce-lung-toxicity-in-radiation-therapy/PRIME-LUNG: https://thoraciconcology.org.au/news/clinical-trials/prof-siva-receives-1-5m-funding-for-prime-lung/MODERN LUNG: https://thoraciconcology.org.au/clinical-trials/25-003-modern-lung/ (00:00) Welcome and Overview(02:38) SABR Basics and Eligibility(04:17) SABR for Operable Patients(05:31) SABR Advances and Short Courses(07:33) SABR in Stage III and IV(14:08) Immunotherapy with Early SABR(16:02) Modern Tech for Stage III RT(20:25) New Organs at Risk(23:49) Australian Trials Vital and Modern Lung(27:51) Access for Rural Patients(30:06) Future of Lung Radiotherapy(35:00) Closing and Call to Action ---------------Support TOGAThank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.---------------Connect with TOGAAttend an Event: https://thoraciconcology.org.au/events/Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/Follow UsLinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/X (Twitter): https://x.com/TOGAANZInstagram: https://www.instagram.com/togaanz/YouTube: https://www.youtube.com/@Thoracic_Oncology---------------Acknowledgement of CountryThe Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.













